BridgeBio Pharma (BBIO) EPS (Basic) (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.15% |
| Dec 31, 2025 | -4.21% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -7.95% |
| Mar 31, 2025 | 38.03% |
| Dec 31, 2024 | -65.12% |
| Sep 30, 2024 | -120.51% |
| Jun 30, 2024 | -95.00% |
| Mar 31, 2024 | 79.17% |
| Dec 31, 2023 | 11.11% |
| Sep 30, 2023 | -10.20% |
| Jun 30, 2023 | -6.52% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 1.08% |
| Sep 30, 2022 | -1,228.57% |
| Jun 30, 2022 | 94.81% |
| Mar 31, 2022 | -32.35% |
| Dec 31, 2021 | 3.77% |
| Sep 30, 2021 | -60.61% |
| Jun 30, 2021 | 44.07% |
| Mar 31, 2021 | -16.83% |
| Dec 31, 2020 | -3.06% |
| Sep 30, 2020 | 4.85% |
| Jun 30, 2020 | -32.05% |
| Mar 31, 2020 | -25.81% |
| Dec 31, 2019 | -21.57% |
| Sep 30, 2019 | 28.17% |
| Jun 30, 2019 | -7.58% |
| Mar 31, 2019 | -26.92% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 69.59% |